These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24929527)

  • 1. Small-molecule modulation of Ras signaling.
    Spiegel J; Cromm PM; Zimmermann G; Grossmann TN; Waldmann H
    Nat Chem Biol; 2014 Aug; 10(8):613-22. PubMed ID: 24929527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C.
    Hunter JC; Gurbani D; Ficarro SB; Carrasco MA; Lim SM; Choi HG; Xie T; Marto JA; Chen Z; Gray NS; Westover KD
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8895-900. PubMed ID: 24889603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Getting a Handle on RAS-targeted Therapies: Cysteine Directed Inhibitors.
    Huynh MV; Campbell SL
    Mini Rev Med Chem; 2016; 16(5):383-90. PubMed ID: 26423694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant-Specific Targeting of Ras G12C Activity by Covalently Reacting Small Molecules.
    Goody RS; Müller MP; Rauh D
    Cell Chem Biol; 2019 Oct; 26(10):1338-1348. PubMed ID: 31378709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of RAS: New hope for drugging the "undruggable".
    Khan I; Rhett JM; O'Bryan JP
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118570. PubMed ID: 31678118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele.
    Zhang Y; Larraufie MH; Musavi L; Akkiraju H; Brown LM; Stockwell BR
    Biochemistry; 2018 Feb; 57(8):1380-1389. PubMed ID: 29313669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.
    Wang Y; Kaiser CE; Frett B; Li HY
    J Med Chem; 2013 Jul; 56(13):5219-30. PubMed ID: 23566315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Inhibitors of Ras-Effector Protein Interactions.
    Upadhyaya P; Bedewy W; Pei D
    Mini Rev Med Chem; 2016; 16(5):376-82. PubMed ID: 26423701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.
    Scheffzek K; Ahmadian MR; Kabsch W; Wiesmüller L; Lautwein A; Schmitz F; Wittinghofer A
    Science; 1997 Jul; 277(5324):333-8. PubMed ID: 9219684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural basis for the transition from Ras-GTP to Ras-GDP.
    Hall BE; Bar-Sagi D; Nassar N
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12138-42. PubMed ID: 12213964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of the development of Ras inhibitors.
    Shima F; Matsumoto S; Yoshikawa Y; Kawamura T; Isa M; Kataoka T
    J Biochem; 2015 Aug; 158(2):91-9. PubMed ID: 26100833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renaissance of Ras.
    Milroy LG; Ottmann C
    ACS Chem Biol; 2014 Nov; 9(11):2447-58. PubMed ID: 25148694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras signalling. Caught in the act of the switch-on.
    Wittinghofer F
    Nature; 1998 Jul; 394(6691):317, 319-20. PubMed ID: 9690464
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitors of Ras-SOS Interactions.
    Lu S; Jang H; Zhang J; Nussinov R
    ChemMedChem; 2016 Apr; 11(8):814-21. PubMed ID: 26630662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RasIns: Genetically Encoded Intrabodies of Activated Ras Proteins.
    Cetin M; Evenson WE; Gross GG; Jalali-Yazdi F; Krieger D; Arnold D; Takahashi TT; Roberts RW
    J Mol Biol; 2017 Feb; 429(4):562-573. PubMed ID: 27865780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in cancer drug discovery targeting RAS.
    Wilson CY; Tolias P
    Drug Discov Today; 2016 Dec; 21(12):1915-1919. PubMed ID: 27506872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Past, Present, and Future of Targeting Ras for Cancer Therapies.
    Tan Z; Zhang S
    Mini Rev Med Chem; 2016; 16(5):345-57. PubMed ID: 26423695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Approaches to RAS Mutation.
    Scott AJ; Lieu CH; Messersmith WA
    Cancer J; 2016; 22(3):165-74. PubMed ID: 27341593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a peptidic ligand for Ras.
    Gareiss PC; Schneekloth AR; Salcius MJ; Seo SY; Crews CM
    Chembiochem; 2010 Mar; 11(4):517-22. PubMed ID: 20082398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Ras-related proteins talk to their effectors.
    Wittinghofer A; Nassar N
    Trends Biochem Sci; 1996 Dec; 21(12):488-91. PubMed ID: 9009833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.